Inclusion body myositis: a case with associated collagen vascular disease responding to treatment.
Patients with inclusion body myositis demonstrate characteristic histological and electronmicroscopical abnormalities in muscle and are generally considered refractory to treatment. A patient with inclusion body myositis is described with evidence of associated autoimmune disease, who responded to steroids.
Lane
R J
RJ
Fulthorpe
J J
JJ
Hudgson
P
P
D001379:Azathioprine / Q000627:therapeutic use*; D002467:Cell Nucleus / Q000648:ultrastructure; D003882:Dermatomyositis / Q000188:drug therapy / Q000473:pathology*; D004359:Drug Therapy, Combination; D006801:Humans; D002479:Inclusion Bodies / Q000648:ultrastructure*; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D009132:Muscles / Q000473:pathology; D009133:Muscular Atrophy / Q000473:pathology; D009220:Myositis / Q000188:drug therapy / Q000473:pathology*; D011241:Prednisone / Q000627:therapeutic use*; D014617:Vacuoles / Q000648:ultrastructure
D001379:Azathioprine; D011241:Prednisone